Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: on-treatment kinetics of HBsAg serum levels vary by HBV genotype.

MLA

Brunetto, Maurizia R., et al. “Response to Peginterferon Alfa-2a (40KD) in HBeAg-Negative CHB: On-Treatment Kinetics of HBsAg Serum Levels Vary by HBV Genotype.” Journal of Hepatology, vol. 59, no. 6, Dec. 2013, pp. 1153–59. EBSCOhost, https://doi.org/10.1016/j.jhep.2013.07.017.

APA

Brunetto, M. R., Marcellin, P., Cherubini, B., Yurdaydin, C., Farci, P., Hadziyannis, S. J., Rothe, V., Regep, L., & Bonino, F. (2013). Response to peginterferon alfa-2a (40KD) in HBeAg-negative CHB: on-treatment kinetics of HBsAg serum levels vary by HBV genotype. Journal of Hepatology, 59(6), 1153–1159. https://doi.org/10.1016/j.jhep.2013.07.017

Chicago

Brunetto, Maurizia R, Patrick Marcellin, Beatrice Cherubini, Cihan Yurdaydin, Patrizia Farci, Stephanos J Hadziyannis, Vivien Rothe, Loredana Regep, and Ferruccio Bonino. 2013. “Response to Peginterferon Alfa-2a (40KD) in HBeAg-Negative CHB: On-Treatment Kinetics of HBsAg Serum Levels Vary by HBV Genotype.” Journal of Hepatology 59 (6): 1153–59. doi:10.1016/j.jhep.2013.07.017.